ArticleRMD open2018

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies.

Jürgen Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.